Manufacturers Life Insurance Company, The Argenx Se Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Argenx Se stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 61,586 shares of ARGX stock, worth $34.7 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
61,586
Previous 55,435
11.1%
Holding current value
$34.7 Million
Previous $23.8 Million
40.11%
% of portfolio
0.03%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding ARGX
# of Institutions
400Shares Held
30.9MCall Options Held
376KPut Options Held
489K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.28 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$1.98 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.4 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$959 Million0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$699 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $31.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...